Cargando…
Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports
BACKGROUND: True hypersensitivity reactions to rifampicin are relatively rare, nonetheless severe manifestations mostly involving a single organ have been documented. We report a case of acute multi-organ failure occurring after a medication error with re-exposure to rifampicin. CASE PRESENTATION: A...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373162/ https://www.ncbi.nlm.nih.gov/pubmed/30755272 http://dx.doi.org/10.1186/s40360-019-0289-7 |
_version_ | 1783394921660547072 |
---|---|
author | Brockhaus, Lisa Schmid, Yasmin Rast, Anna C. Rätz Bravo, Alexandra E. Hofmeier, Kathrin Scherer Leuppi-Taegtmeyer, Anne B. |
author_facet | Brockhaus, Lisa Schmid, Yasmin Rast, Anna C. Rätz Bravo, Alexandra E. Hofmeier, Kathrin Scherer Leuppi-Taegtmeyer, Anne B. |
author_sort | Brockhaus, Lisa |
collection | PubMed |
description | BACKGROUND: True hypersensitivity reactions to rifampicin are relatively rare, nonetheless severe manifestations mostly involving a single organ have been documented. We report a case of acute multi-organ failure occurring after a medication error with re-exposure to rifampicin. CASE PRESENTATION: A 68-year old patient developed acute hypersensitivity pneumonitis, acute renal failure, acute liver failure and haemolytic anemia within hours after a second re-exposure to Rifampicin for the treatment of a hip prosthesis infection with Staphylococcus epidermidis. A recent rifampicin exposure 1 week earlier had resulted in a massive rise of CRP levels without organ manifestations. Nine years previously, the patient had developed a multi-organ hypersensitivity reaction 8 days after commencing treatment with rifampicin for pulmonary tuberculosis; and 23 years previously he had received rifampicin without problems. The organ-specific hypersensitivity reactions were largely reversible after withdrawal of rifampicin and treatment with steroids. A review of the literature and summary of WHO spontaneous safety reports is also given. CONCLUSIONS: Re-exposure to rifampicin in sensitised individuals may cause acute severe hypersensitivity reactions. Due to its indications in the management of mycobacterial and implant-associated infections, rifampicin is a drug which might be given decades apart, which poses a risk that information about previous intolerance is lost. |
format | Online Article Text |
id | pubmed-6373162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63731622019-02-25 Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports Brockhaus, Lisa Schmid, Yasmin Rast, Anna C. Rätz Bravo, Alexandra E. Hofmeier, Kathrin Scherer Leuppi-Taegtmeyer, Anne B. BMC Pharmacol Toxicol Case Report BACKGROUND: True hypersensitivity reactions to rifampicin are relatively rare, nonetheless severe manifestations mostly involving a single organ have been documented. We report a case of acute multi-organ failure occurring after a medication error with re-exposure to rifampicin. CASE PRESENTATION: A 68-year old patient developed acute hypersensitivity pneumonitis, acute renal failure, acute liver failure and haemolytic anemia within hours after a second re-exposure to Rifampicin for the treatment of a hip prosthesis infection with Staphylococcus epidermidis. A recent rifampicin exposure 1 week earlier had resulted in a massive rise of CRP levels without organ manifestations. Nine years previously, the patient had developed a multi-organ hypersensitivity reaction 8 days after commencing treatment with rifampicin for pulmonary tuberculosis; and 23 years previously he had received rifampicin without problems. The organ-specific hypersensitivity reactions were largely reversible after withdrawal of rifampicin and treatment with steroids. A review of the literature and summary of WHO spontaneous safety reports is also given. CONCLUSIONS: Re-exposure to rifampicin in sensitised individuals may cause acute severe hypersensitivity reactions. Due to its indications in the management of mycobacterial and implant-associated infections, rifampicin is a drug which might be given decades apart, which poses a risk that information about previous intolerance is lost. BioMed Central 2019-02-12 /pmc/articles/PMC6373162/ /pubmed/30755272 http://dx.doi.org/10.1186/s40360-019-0289-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Brockhaus, Lisa Schmid, Yasmin Rast, Anna C. Rätz Bravo, Alexandra E. Hofmeier, Kathrin Scherer Leuppi-Taegtmeyer, Anne B. Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports |
title | Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports |
title_full | Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports |
title_fullStr | Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports |
title_full_unstemmed | Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports |
title_short | Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports |
title_sort | hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including who spontaneous safety reports |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373162/ https://www.ncbi.nlm.nih.gov/pubmed/30755272 http://dx.doi.org/10.1186/s40360-019-0289-7 |
work_keys_str_mv | AT brockhauslisa hypersensitivityreactionwithmultiorganfailurefollowingreexposuretorifampicincasereportandreviewoftheliteratureincludingwhospontaneoussafetyreports AT schmidyasmin hypersensitivityreactionwithmultiorganfailurefollowingreexposuretorifampicincasereportandreviewoftheliteratureincludingwhospontaneoussafetyreports AT rastannac hypersensitivityreactionwithmultiorganfailurefollowingreexposuretorifampicincasereportandreviewoftheliteratureincludingwhospontaneoussafetyreports AT ratzbravoalexandrae hypersensitivityreactionwithmultiorganfailurefollowingreexposuretorifampicincasereportandreviewoftheliteratureincludingwhospontaneoussafetyreports AT hofmeierkathrinscherer hypersensitivityreactionwithmultiorganfailurefollowingreexposuretorifampicincasereportandreviewoftheliteratureincludingwhospontaneoussafetyreports AT leuppitaegtmeyeranneb hypersensitivityreactionwithmultiorganfailurefollowingreexposuretorifampicincasereportandreviewoftheliteratureincludingwhospontaneoussafetyreports |